EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Asia Pacific

Singapore biotech startup raises $10M to enhance drug discovery

The money will be used to further develop its drug discovery platform, hire more scientists in its home bases of San Francisco and Singapore and pursue medical studie...
Continue Reading →
news

ERT Expands Respiratory Solutions to Support New Endpoints

Industry-leading MasterScope™ integration provides centralized Forced Oscillation Technique services to deliver high quality data while lessening patient and site bur...
Continue Reading →
Europe

Medicalchain to present to Mayo Clinic

Robert Miller to talk about blockchain, healthcare, and ICOs. Robert Miller, Director of Business Development at Medicalchain, will be presenting to Mayo Clinic on Mo...
Continue Reading →
Europe

DNA Script and Dynamic Combinatorial Chemistry enter exclusive partnership to enable enzymatically synthesized DNA

Partnership is a key milestone in DNA Script's progress toward commercializing its high speed, high efficiency, free-of-harsh-chemicals, DNA synthesis technology. DNA...
Continue Reading →
Europe

Repurposed drug found to be effective against Zika virus

In both cell cultures and mouse models, a drug used to treat Hepatitis C effectively protected and rescued neural cells infected by the Zika virus - and blocked trans...
Continue Reading →
Europe

FDA approves new treatment for certain digestive tract cancers

The U.S. Food and Drug Administration today approved Lutathera (lutetium Lu 177 dotatate) for the treatment of a type of cancer that affects the pancreas or gastroint...
Continue Reading →
news

Meta-Analysis Shows One Kind of Brain Training Does Work

A systematic review and meta-analysis has just published in Neuroscience and Biobehavioral Reviews, and concludes that a specific type of computerized brain training ...
Continue Reading →
news

INC Research/inVentiv Health Becomes Syneos HealthTM

INC Research/inVentiv Health (Nasdaq: INCR) today announced it has changed its brand identity to Syneos Health, Inc., effective January 4, 2018. More than 21,000 of t...
Continue Reading →
Europe

Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent®(alirocumab)

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent in...
Continue Reading →
news

Breast cancer death rate drops by almost 40 percent in U.S.

Breast cancer is the most common cancer diagnosed in U.S. women and the second-leading cause of death after lung cancer. About 252,000 new cases of breast cancer are ...
Continue Reading →
Quotient